Written by Akanksha Jayanthi
The Healthcare Supply Chain Association of America has released a report on the role of group purchasing organizations in managing and alleviating drug shortages in the United States.
The report outlines the ongoing causes and ramifications of drug shortages, what GPOs can do to help the situation and policy recommendations to help address the problem.
Here are four things to know about drug shortages from the HSCA's report.
1. The number of active drug shortages has been relatively static over the past two years. At the end of the first quarter of 2014, there were 305 active drug shortages. The number of active shortages has remained relatively steady since the third quarter of 2012, with an average of 295 shortages. However, this is almost double the 152 active shortages at the end of the first quarter of 2010.
continue to read here
The Healthcare Supply Chain Association of America has released a report on the role of group purchasing organizations in managing and alleviating drug shortages in the United States.
The report outlines the ongoing causes and ramifications of drug shortages, what GPOs can do to help the situation and policy recommendations to help address the problem.
Here are four things to know about drug shortages from the HSCA's report.
1. The number of active drug shortages has been relatively static over the past two years. At the end of the first quarter of 2014, there were 305 active drug shortages. The number of active shortages has remained relatively steady since the third quarter of 2012, with an average of 295 shortages. However, this is almost double the 152 active shortages at the end of the first quarter of 2010.
continue to read here
No comments:
Post a Comment